Skip to main content

Kontrastmittelunterstützte Mammographie

Contrast-enhanced mammography

Zusammenfassung

Eine frühzeitige Erkennung ist für die erfolgreiche Behandlung des Mammakarzinoms sowie für eine gute Prognose von großer Bedeutung. Die Kontrastmittelmammographie und insbesondere die kontrastmittelverstärkte spektrale Mammographie (CESM) zeigt vielversprechende erste Ergebnisse und stellt eine wertvolle Ergänzung zu den derzeit verfügbaren Methoden dar. Der Vorteil dieses Verfahrens besteht darin, dass eine Bildgebung beider Brüste in nur einem Untersuchungsgang mit einer Kontrastmittelgabe erfolgen kann. Die CESM zeigt ähnlich gute Resultate wie die Magnetresonanztomographie (MRT), ist gut verfügbar und kostengünstig und findet daher zunehmend Anwendung in der Mammadiagnostik. Die CESM stellt auch eine gute Alternative zur MRT dar, wenn diese aufgrund von Kontraindikationen nicht durchgeführt werden kann.

Abstract

Early detection is of great importance for the successful treatment of breast cancer and for a good prognosis. Contrast-enhanced mammography and especially contrast-enhanced spectral mammography (CESM) show promising initial results and are a valuable addition to currently available methods. The advantage of these methods is that imaging of both breasts can be performed in a single examination with a single contrast agent application. The accuracy of CESM is similar to that of magnetic resonance imaging (MRI), easily available at low costs, which is why this procedure is increasingly used in the diagnostic work up of breast cancer. CESM is also a good alternative to MRI if this cannot be performed due to contraindications.

This is a preview of subscription content, access via your institution.

Abb. 1
Abb. 2

Abbreviations

AGD:

Average glandular dose

CEDM:

Contrast enhanced dual energy mammography

CESM:

Contrast enhanced spectral mammography

HE:

High energy

LE:

Low energy

MG:

Mammographie

MRT:

Magnetresonanztomographie

Literatur

  1. Bakker MF, De Lange SV, Pijnappel RM et al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381:2091–2102

    Article  Google Scholar 

  2. Diekmann F, Diekmann S, Jeunehomme F et al (2005) Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement. Invest Radiol 40:397–404

    Article  Google Scholar 

  3. Diekmann F, Diekmann S, Taupitz M et al (2003) Use of iodine-based contrast media in digital full-field mammography—initial experience. Rofo 175:342–345

    CAS  Article  Google Scholar 

  4. Diekmann F, Freyer M, Diekmann S et al (2011) Evaluation of contrast-enhanced digital mammography. Eur J Radiol 78:112–121

    Article  Google Scholar 

  5. Dromain C, Balleyguier C, Muller S et al (2006) Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography. AJR Am J Roentgenol 187:W528–537

    Article  Google Scholar 

  6. Dromain C, Thibault F, Diekmann F et al (2012) Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study. Breast Cancer Res 14:R94

    Article  Google Scholar 

  7. Dromain C, Thibault F, Muller S et al (2011) Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol 21:565–574

    Article  Google Scholar 

  8. Eskin BA, Parker JA, Bassett JG et al (1974) Human breast uptake of radioactive iodine. Obstet Gynecol 44:398–402

    CAS  PubMed  Google Scholar 

  9. Esserman L, Cowley H, Eberle C et al (2002) Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst 94:369–375

    Article  Google Scholar 

  10. Pisano ED, Hendrick RE, Yaffe MJ, Baum JK, Acharyya S, Cormack JB, Hanna LA, Conant EF, Fajardo LL, Bassett LW, D’Orsi CJ, Jong RA, Rebner M, Tosteson AN, Gatsonis CA, DMIST Investigators Group (2008) Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 246(2):376–383. https://doi.org/10.1148/radiol.2461070200

  11. Fallenberg EM, Dromain C, Diekmann F et al (2014) Contrast-enhanced spectral mammography versus MRI: initial results in the detection of breast cancer and assessment of tumour size. Eur Radiol 24:256–264

    CAS  Article  Google Scholar 

  12. Fallenberg EM, Dromain C, Diekmann F et al (2014) Contrast-enhanced spectral mammography: does mammography provide additional clinical benefits or can some radiation exposure be avoided? Breast Cancer Res Treat 146:371–381

    CAS  Article  Google Scholar 

  13. Fallenberg EM, Schmitzberger FF, Amer H et al (2017) Contrast-enhanced spectral mammography vs. mammography and MRI—clinical performance in a multi-reader evaluation. Eur Radiol 27:2752–2764

    Article  Google Scholar 

  14. Ferno M (1998) Prognostic factors in breast cancer: a brief review. Anticancer Res 18:2167–2171

    CAS  PubMed  Google Scholar 

  15. Froeling V, Diekmann F, Renz DM et al (2013) Correlation of contrast agent kinetics between iodinated contrast-enhanced spectral tomosynthesis and gadolinium-enhanced MRI of breast lesions. Eur Radiol 23:1528–1536

    Article  Google Scholar 

  16. Jochelson MS, Dershaw DD, Sung JS et al (2013) Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 266:743–751

    Article  Google Scholar 

  17. Jong RA, Yaffe MJ, Skarpathiotakis M et al (2003) Contrast-enhanced digital mammography: initial clinical experience. Radiology 228:842–850

    Article  Google Scholar 

  18. Kalager M, Haldorsen T, Bretthauer M et al (2009) Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res 11:R44

    Article  Google Scholar 

  19. Lalji UC, Houben IP, Prevos R et al (2016) Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study. Eur Radiol 26:4371–4379

    CAS  Article  Google Scholar 

  20. Lobbes MB, Lalji U, Houwers J et al (2014) Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme. Eur Radiol 24:1668–1676

    PubMed  Google Scholar 

  21. Luczynska E, Heinze-Paluchowska S, Dyczek S et al (2014) Contrast-enhanced spectral mammography: comparison with conventional mammography and histopathology in 152 women. Korean J Radiol 15:689–696

    Article  Google Scholar 

  22. Mokhtar O, Mahmoud S (2014) Can contrast enhanced mammography solve the problem of dense breast lesions? Egypt J Radiol Nucl Med 45:1043–1052

    Article  Google Scholar 

  23. Perry N, Broeders M, De Wolf C et al (2008) European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Ann Oncol 19:614–622

    CAS  Article  Google Scholar 

  24. Saadatmand S, Obdeijn IM, Rutgers EJ et al (2015) Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). International journal of cancer. J Int Cancer 137:1729–1738

    CAS  Article  Google Scholar 

  25. Tabar L, Vitak B, Chen TH et al (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260:658–663

    Article  Google Scholar 

  26. Tennant SL, James JJ, Cornford EJ et al (2016) Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting. Clin Radiol 71:1148–1155

    CAS  Article  Google Scholar 

  27. Wanders JOP, Holland K, Karssemeijer N et al (2017) The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study. Breast Cancer Res 19:67

    Article  Google Scholar 

  28. Weigel S, Heindel W, Heidrich J et al (2017) Digital mammography screening: sensitivity of the programme dependent on breast density. Eur Radiol 27:2744–2751

    Article  Google Scholar 

  29. Wockel A, Festl J, Stuber T et al (2018) Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-level, AWMF registry number 032/045OL, december 2017)—part 1 with recommendations for the screening, diagnosis and therapy of breast cancer. Geburtshilfe Frauenheilkd 78:927–948

    Article  Google Scholar 

  30. Xing D, Lv Y, Sun B et al (2019) Diagnostic value of contrast-enhanced spectral mammography in comparison to magnetic resonance imaging in breast lesions. J Comput Assist Tomogr 43:245–251

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Eva M. Fallenberg.

Ethics declarations

Interessenkonflikt

E.M. Fallenberg ist als Referent für die Firmen GE Healthcare, Siemens Healthineers, Bayer Healthcare und Guerbet tätig und die Klinik hat für Ihre Projekte Forschungsförderungen von GE Healthcare, Bayer, Guerbet und Siemens erhalten.

Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fallenberg, E.M. Kontrastmittelunterstützte Mammographie. Radiologe 61, 177–182 (2021). https://doi.org/10.1007/s00117-021-00805-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-021-00805-7

Schlüsselwörter

  • Brustkrebs
  • Früherkennung
  • Qualitätskontrolle
  • Kontrastmittelverstärkte spektrale Mammographie
  • Magnetresonanztomographie

Keywords

  • Breast cancer
  • Early diagnosis
  • Quality control
  • Contrast-enhanced spectral mammography
  • Magnetic resonance imaging